SuSoS AG

HekeTiss, a UNIGE/HUG spin-off, enhances lives by pioneering cell-therapy treatments for ulcerative skin conditions. Innovating for a healthier tomorrow.

FatiAbGen International is the Swiss subsidiary of FatiAbGen Co. Ltd., established in Korea in 2020. We engineer best in class antibodies tailored for multiple modalities such as ADCs and bi-specifics. We then develop targeted molecules to address high unmet need diseases in oncology and immunology.

GTP Bioways is a French-based CDMO that prioritizes customized services supporting biopharmaceutical companies throughout their journey from R&D to clinics. With more than 20 years’ experience, we specialize in process development and GMP manufacturing of biologics, bioconjugates and nanodrugs.